4th Nasal Formulation and Delivery Summit

The 4th Nasal Formulation and Delivery Summit is uniting formulation, delivery, and product development leaders from across pharma and biotech to advance the development of safe, effective, and commercially viable intranasal therapies. As intranasal delivery gains validation across systemic, CNS, and emergency-use indications, the pressure to optimize formulations, align drug–device strategies, and generate predictive preclinical and clinical data has never been greater. 

In an era of accelerating approvals, expanding modalities, and heightened regulatory scrutiny, teams must move beyond proof-of-concept to ensure intranasal programs are scalable, translatable, and fit for commercialization. Success now depends on solving formulation and delivery challenges early, while designing development strategies that withstand clinical, regulatory, and manufacturing demands. 

This year, join 70+ experts from Eli Lilly, Bayer, Neurelis, Virpax Pharmaceuticals, Belhaven Biopharma, and more to explore real-world preclinical and clinical data, compare liquid and powder nasal approaches, and align on best practices for systemic and nose-to-brain delivery. Don't miss the only industry-led meeting dedicated exclusively to end-to-end intranasal formulation, delivery, and commercialization.  

URLs:
Website: https://go.evvnt.com/3457175-0?pid=185
Tickets: https://go.evvnt.com/3457175-2?pid=185
Brochure: https://go.evvnt.com/3457175-3?pid=185

Prices:
Drug Developer Pricing - Conference Only: USD 3099.00,
Drug Developer Pricing - Conference + 1 Workshop: USD 3748.00,
Drug Developer Pricing - Conference + 2 Workshops: USD 4397.00,
Academic Pricing - Conference Only: USD 2699.00,
Academic Pricing - Conference + 1 Workshop: USD 3248.00,
Academic Pricing - Conference + 2 Workshops: USD 3797.00,
Solution Provider Pricing - Conference Only: USD 3799.00,
Solution Provider Pricing - Conference + 1 Workshop: USD 4548.00,
Solution Provider Pricing - Conference + 2 Workshops: USD 5297.00

Speakers: Sebastien Pradel, Senior Scientist, Translational Chemistry, AltPep Corporation, Kinkini Roy, PhD, Associate Director - Drug Product Development, Aviceda Therapeutics, Deb Das, Senior Associate Director, Formulation Development and Fellow, Bayer, Scott Lyman, Chief Executive Officer, Belhaven Biopharma, Ryan Kole, Co-Founder and Chief Executive Officer, Beyond Barriers Therapeutics, Inc., Mazin Hakim, Advisor, Eli Lilly and Co., Subramanya Prasad Peri, Assistant Vice President - Regulatory Affairs Connected Delivery Devices, and Digital Health, Eli Lilly and Co., Jianxin Bao, Co-Founder and Chief Executive Officer, Gateway Biotechnology Inc., Alice Stanton, Assistant Professor, Harvard Medical School, Ismail Hafez, Director - Formulation and Delivery Sciences, Ionis Pharmaceuticals, Inc., Dylan Verden, Chief Science Officer, KIF1A.ORG, Gavin Gear, President and CEO, Logix Biosciences, Dan Teleman, Chief Executive Officer, Nasus Pharma, Stuart Madden, Chief Scientific Officer, Neurelis, Inc, Parnian Lak, Founder and Chief Executive Officer, Olfera, Jake VanLandingham, Lead Scientist, Oragenics Health, Laleh Golshahi, Engineering Foundation Professor, Virginia Commonwealth University, Sheila Mathias, Chief Scientific Officer, Virpax Pharmaceuticals

Category: Conferences | Science, Health and Medicine | Pharmaceuticals

Date and Time: 19th May 2026 at 8:00 am to 21st May 2026 at 3:35 pm

Venue details: Hilton Boston Logan Airport, One Hotel Drive, Boston, Massachusetts, 02128, United States